Know Cancer

or
forgot password

A Phase 1 Trial of ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer


Phase 1
18 Years
N/A
Not Enrolling
Both
Metastases, Cancer

Thank you

Trial Information

A Phase 1 Trial of ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer


Inclusion Criteria:



- Histologic or cytologic diagnosis of metastatic or locally advanced cancer

- Prior chemotherapy is allowed

- Adequate bone marrow, liver and kidney function

Exclusion Criteria:

- Prior treatment with ALIMTA

- Brain metastasis

- Pregnancy or breast feeding

Type of Study:

Interventional

Study Design:

Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

1310

NCT ID:

NCT00034463

Start Date:

Completion Date:

Related Keywords:

  • Metastases
  • Cancer
  • metastatic cancer
  • chemotherapy
  • Neoplasm Metastasis
  • Neoplasms
  • Neoplasms, Second Primary

Name

Location

For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician.San Antonio, Texas